JournalArta
Sunday, November 22, 2026 · JakartaS&P 6,910.39 ▼3.70%USD/IDR 18,158 ▼0.42%
JournalArta
Global Edition
beyond headlines
Advertisement

Momentum Weakens, GSK Stock Gains 1.42% on Wednesday

On October 7, 2026: price 1,790.50 GBp, trend downtrend, RSI 40.3, support 1,759.00, resistance 1,911.00. technical analysis of gsk stock.

By Elena Vance
WIB5 min read
Momentum Weakens, GSK Stock Gains 1.42% on Wednesday
Momentum Weakens, GSK Stock Gains 1.42% on Wednesday

Why GSK is in focus today

  • Downtrend extending (5-day change -2.27%)
  • Not covered by JournalArta in the last 14 days

Selected automatically from 16 LSE (UK) stocks by a technical-signal score with daily weighted randomisation — not a recommendation.

GSK rose 1.42% to 1,790.50 GBp on 8 October, according to exchange data carried, but the daily gain sits against a weaker five-day trend and a price still below its key moving averages. The stock is worth watching because its decline has continued over that period, while the latest trading volume was exceptionally thin. That makes the rebound a tentative signal, not yet evidence that selling pressure has ended. GSK fell 2.27% over five days and 0.72% over one month. Its 20-day average is also sloping down, a sign that recent weakness is not confined to a single session.
Advertisement

Trend & Price Action

The shares trade below the SMA20 at 1,838.30 GBp and the SMA50 at 1,868.53 GBp. A simple moving average tracks the average price over a set period; when the share price sits beneath both, it indicates that recent trading remains weaker than those longer reference points. There has been no new moving-average crossover to suggest a confirmed change in direction. The 20-day average has fallen 0.70% over five days, reinforcing the downtrend. GSK is near the lower part of its stated 20-day range: support is 1,759.00 GBp and resistance is 1,911.00 GBp, with the price at 21% of that range. The position leaves room for a technical bounce, but does not by itself establish a reversal.
Price action chart of GSK
3-month price action chart of GSK: price, SMA20/50, Bollinger, support & resistance. Data: exchange.
Advertisement
The three-month high is 2,096.00 GBp. The supplied three-month low is listed as 0.00, which is not a usable trading reference; the 20-day support level is therefore more relevant for assessing near-term price action.

Oscillators & Momentum

Momentum readings are mixed, with the broader signal still leaning negative. The RSI is 40.3, in neutral territory. The Relative Strength Index measures the pace of recent gains and losses; this reading is below the midpoint but does not indicate an extreme condition. The Stochastic reading is more stretched: %K at 93.4 is overbought, while %D is 36.7. Stochastic compares a closing price with its recent trading range. The sharp gap between the two lines can signal a short-term surge that may be vulnerable to fading, particularly when the wider trend is down. The MACD is negative at -24.363, below its -15.678 signal line, with a negative histogram of -8.685. MACD compares moving averages to gauge momentum; these readings suggest downside pressure remains in place rather than confirming the latest one-day rise as a durable shift.
Momentum chart of GSK
Momentum chart of GSK: RSI(14), MACD, Stochastic. Data: exchange.
Advertisement

Volatility & Volume

GSK’s Bollinger Bands are neither especially tight nor unusually wide: the band width is 10.8%, classified as normal. The %B reading of 26% places the share closer to the lower band than the upper one, consistent with its position below the 20-day average. The bands run from 1,739.34 GBp to 1,937.26 GBp, with the middle line at 1,838.30 GBp. Bollinger Bands show how far price has moved from its recent average; proximity to the lower band reflects weakness, but is not a stand-alone reversal signal. Volatility is high: the 14-day ATR is 167.52 GBp, or 9.4% of the share price. ATR estimates the typical size of price moves, not their direction. That scale means movements around support or resistance could be substantial. Participation in the latest rise was notably weak. Volume was 101,885 shares, against a 20-day average of 6,176,648, while OBV was falling. OBV tracks whether volume tends to accompany rising or falling prices. Together, these readings weaken the case that the one-day rebound reflects broad buying interest.
Advertisement

Key Levels & Scenarios

The first test is support at 1,759.00 GBp. A failure to hold it would add pressure to an already negative MACD and down-sloping average. On the upside, 1,838.30 GBp, the SMA20, is the initial hurdle; the share would then need to contend with resistance at 1,911.00 GBp. A move through those levels would improve the chart’s tone, but the weak volume means confirmation matters.

Technical Verdict: HOLD (wait & see)

The indicators support a wait-and-see reading: the price remains below both moving averages, MACD momentum is negative, and falling OBV alongside very low volume does not confirm the daily rebound. The neutral RSI and proximity to support argue against treating the chart as an unambiguous continuation signal.
  • Ideal entry range: 1,759.00–1,838.30 GBp, bounded by 20-day support and the SMA20.
  • Exit target: 1,911.00 GBp, the 20-day resistance level.
  • Stop-loss protection: below 1,739.34 GBp, the lower Bollinger Band.
Advertisement
The verdict is invalidated if the price falls below 1,759.00 GBp, because that would break the stated 20-day support. In plain English, the chart has not yet shown enough confirmation to distinguish a brief bounce from a lasting recovery.
IndicatorReading
Last price1,790.50 GBp
Five-day change-2.27%
SMA20 / SMA501,838.30 / 1,868.53 GBp
RSI(14)40.3, neutral
Stochastic %K / %D93.4 / 36.7; %K overbought
MACD / signal / histogram-24.363 / -15.678 / -8.685
20-day support / resistance1,759.00 / 1,911.00 GBp
ATR(14)167.52 GBp; 9.4% of price

Summary Data GSK

Last price1,790.50 GBp
Change 1 day / 5 days / 1 month1.42% / -2.27% / -0.72%
Trend / MA-crossdowntrend / none
SMA20 / SMA501,838.30 / 1,868.53
RSI (14) / Stochastic %K40.3 / 93.4
Bollinger %B / ATR26% / 167.52
Support / Resistance 20 days1,759.00 / 1,911.00
Data as of8 October 2026 00:04 WIB
Advertisement

Disclaimer: This technical analysis is generated automatically from exchange data and indicators calculated by JournalArta, for information and education only. The verdict and the entry, target and stop-loss levels are not investment advice or a solicitation to buy or sell any security. Investment decisions and their risks rest solely with the reader.

Advertisement
What Kind of Holiday Spender Are You? Take the Black Friday QuizTake the quizWhat Kind of Holiday Spender Are You? Take the Black Friday QuizStart →
Advertisement
Most Read
  1. 1Magnitude 4.2 Earthquake Wakes Los Angeles Before DawnMagnitude 4.2 Earthquake Wakes Los Angeles Before Dawn
  2. 2Micron Says Memory Has Changed as Shares Fall 13.89%Micron Says Memory Has Changed as Shares Fall 13.89%
  3. 3Dow Jones Futures Await Reopening After Tech Stocks SlideDow Jones Futures Await Reopening After Tech Stocks Slide
  4. 4GTA 6 Draws Review Bombing on MetacriticGTA 6 Draws Review Bombing on Metacritic
  5. 5ORCL Stock Week Ahead: Levels and Scenarios for November 23–27ORCL Stock Week Ahead: Levels and Scenarios for November 23–27
Advertisement
Don't Miss

Latest News

All stories →
  1. NYC Weather: Coastal Storm Could Bring Rain and Flight DelaysWorld · United StatesNYC Weather: Coastal Storm Could Bring Rain and Flight DelaysNov 22
  2. Robyn Brings Sydney Crowd to Tears With Final SongLifestyle · EntertainmentRobyn Brings Sydney Crowd to Tears With Final SongNov 22
  3. Vietnam’s Middle Class Grows as Housing and Living Costs RiseBusiness · Macro & PolicyVietnam’s Middle Class Grows as Housing and Living Costs RiseNov 22
  4. Juventus Scores Four Against Venezia After Goalless First HalfSport · FootballJuventus Scores Four Against Venezia After Goalless First HalfNov 22
  5. Advertisement
  6. NCAA FCS Playoff Bracket Due November 22 With 11 Automatic BidsSport · FootballNCAA FCS Playoff Bracket Due November 22 With 11 Automatic BidsNov 22
  7. Ed Miliband Says Closer EU Ties Give UK a Voice on RulesWorld · EuropeEd Miliband Says Closer EU Ties Give UK a Voice on RulesNov 22
  8. Jensen Huang Denies Abuse Claims After Nvidia ExitBusiness · CompaniesJensen Huang Denies Abuse Claims After Nvidia ExitNov 22
  9. Couple Struck by Lightning at Music Festival Say They’re ‘Lucky to Be AliveLifestyleCouple Struck by Lightning at Music Festival Say They’re ‘Lucky to Be AliveNov 22